BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 15758031)

  • 1. Altered nerve excitability properties in established diabetic neuropathy.
    Krishnan AV; Kiernan MC
    Brain; 2005 May; 128(Pt 5):1178-87. PubMed ID: 15758031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activity-dependent excitability changes suggest Na+/K+ pump dysfunction in diabetic neuropathy.
    Krishnan AV; Lin CS; Kiernan MC
    Brain; 2008 May; 131(Pt 5):1209-16. PubMed ID: 18362098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uncovering sensory axonal dysfunction in asymptomatic type 2 diabetic neuropathy.
    Sung JY; Tani J; Chang TS; Lin CS
    PLoS One; 2017; 12(2):e0171223. PubMed ID: 28182728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of membrane polarization and ischaemia on the excitability properties of human motor axons.
    Kiernan MC; Bostock H
    Brain; 2000 Dec; 123 Pt 12():2542-51. PubMed ID: 11099455
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axonal function and activity-dependent excitability changes in myotonic dystrophy.
    Krishnan AV; Kiernan MC
    Muscle Nerve; 2006 May; 33(5):627-36. PubMed ID: 16453325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemia induces paradoxical changes in axonal excitability in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Brain; 2006 Jun; 129(Pt 6):1585-92. PubMed ID: 16636020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progressive axonal dysfunction precedes development of neuropathy in type 2 diabetes.
    Sung JY; Park SB; Liu YT; Kwai N; Arnold R; Krishnan AV; Lin CS
    Diabetes; 2012 Jun; 61(6):1592-8. PubMed ID: 22522615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation in the Na+ channel subunit SCN1B produces paradoxical changes in peripheral nerve excitability.
    Kiernan MC; Krishnan AV; Lin CS; Burke D; Berkovic SF
    Brain; 2005 Aug; 128(Pt 8):1841-6. PubMed ID: 15857929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral nerve excitability measures at different target levels: the effects of aging and diabetic neuropathy.
    Shibuta Y; Nodera H; Mori A; Okita T; Kaji R
    J Clin Neurophysiol; 2010 Oct; 27(5):350-7. PubMed ID: 20844439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropathy, axonal Na+/K+ pump function and activity-dependent excitability changes in end-stage kidney disease.
    Krishnan AV; Phoon RK; Pussell BA; Charlesworth JA; Bostock H; Kiernan MC
    Clin Neurophysiol; 2006 May; 117(5):992-9. PubMed ID: 16516547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nerve excitability changes in critical illness polyneuropathy.
    Z'Graggen WJ; Lin CS; Howard RS; Beale RJ; Bostock H
    Brain; 2006 Sep; 129(Pt 9):2461-70. PubMed ID: 16901913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of experimental focal compression on excitability of human median motor axons.
    Ikemoto T; Tani T; Taniguchi S; Ikeuchi M; Kimura J
    Clin Neurophysiol; 2009 Feb; 120(2):342-7. PubMed ID: 19101203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute tetrodotoxin-induced neurotoxicity after ingestion of puffer fish.
    Kiernan MC; Isbister GK; Lin CS; Burke D; Bostock H
    Ann Neurol; 2005 Mar; 57(3):339-48. PubMed ID: 15732107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evidence of reduced nodal and paranodal conductances in type 1 diabetes.
    Kwai NCG; Arnold R; Poynten AM; Howells J; Kiernan MC; Lin CS; Krishnan AV
    Clin Neurophysiol; 2016 Feb; 127(2):1700-1706. PubMed ID: 26725257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in human sensory axonal excitability induced by an ischaemic insult.
    Han SE; Boland RA; Krishnan AV; Vucic S; Lin CS; Kiernan MC
    Clin Neurophysiol; 2008 Sep; 119(9):2054-63. PubMed ID: 18567535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nerve excitability and structural changes in myelinated axons from diabetic mice.
    Campero M; Ezquer M; Ezquer F
    Exp Clin Endocrinol Diabetes; 2015 Sep; 123(8):485-91. PubMed ID: 26285066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axonal Dysfunction Precedes Motor Neuronal Death in Amyotrophic Lateral Sclerosis.
    Iwai Y; Shibuya K; Misawa S; Sekiguchi Y; Watanabe K; Amino H; Kuwabara S
    PLoS One; 2016; 11(7):e0158596. PubMed ID: 27383069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nerve excitability changes in chronic renal failure indicate membrane depolarization due to hyperkalaemia.
    Kiernan MC; Walters RJ; Andersen KV; Taube D; Murray NM; Bostock H
    Brain; 2002 Jun; 125(Pt 6):1366-78. PubMed ID: 12023325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Axonal dysfunction prior to neuropathy onset in type 1 diabetes.
    Arnold R; Kwai N; Lin CS; Poynten AM; Kiernan MC; Krishnan AV
    Diabetes Metab Res Rev; 2013 Jan; 29(1):53-9. PubMed ID: 23008000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block.
    Kiernan MC; Guglielmi JM; Kaji R; Murray NM; Bostock H
    Brain; 2002 Mar; 125(Pt 3):664-75. PubMed ID: 11872621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.